Penumbra, Inc. (PEN)

USD 238.9

(-3.49%)

Total Debt Summary of Penumbra, Inc.

  • Penumbra, Inc.'s latest annual total debt in 2023 was 234.34 Million USD , down -0.61% from previous year.
  • Penumbra, Inc.'s latest quarterly total debt in 2024 Q3 was 226.68 Million USD , down -0.93% from previous quarter.
  • Penumbra, Inc. reported annual total debt of 235.77 Million USD in 2022, up 35.85% from previous year.
  • Penumbra, Inc. reported annual total debt of 173.54 Million USD in 2021, up 124.58% from previous year.
  • Penumbra, Inc. reported quarterly total debt of 226.68 Million USD for 2024 Q3, down -0.93% from previous quarter.
  • Penumbra, Inc. reported quarterly total debt of 231.43 Million USD for 2024 Q1, down -1.24% from previous quarter.

Annual Total Debt Chart of Penumbra, Inc. (2023 - 2013)

Historical Annual Total Debt of Penumbra, Inc. (2023 - 2013)

Year Total Debt Total Debt Growth
2023 234.34 Million USD -0.61%
2022 235.77 Million USD 35.85%
2021 173.54 Million USD 124.58%
2020 77.27 Million USD -6.1%
2019 82.29 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 6 Million USD 0.0%

Peer Total Debt Comparison of Penumbra, Inc.

Name Total Debt Total Debt Difference
Abbott Laboratories 15.87 Billion USD 98.524%
Allurion Technologies Inc. 41.85 Million USD -459.866%
Artivion, Inc. 359.34 Million USD 34.785%
Avanos Medical, Inc. 209.1 Million USD -12.072%
Butterfly Network, Inc. 25.02 Million USD -836.361%
Butterfly Network, Inc. 25.02 Million USD -836.361%
Bio-Rad Laboratories, Inc. 1.4 Billion USD 83.331%
Boston Scientific Corporation 9.49 Billion USD 97.531%
Perspective Therapeutics, Inc. - USD -Infinity%
CONMED Corporation 991.25 Million USD 76.359%
Edwards Lifesciences Corporation 694.9 Million USD 66.277%
Paragon 28, Inc. 112.03 Million USD -109.179%
Glaukos Corporation 383.73 Million USD 38.932%
Globus Medical, Inc. 520.4 Million USD 54.969%
Inspire Medical Systems, Inc. 24.84 Million USD -843.182%
Integer Holdings Corporation 1.04 Billion USD 77.488%
Medtronic plc 26.04 Billion USD 99.1%
Nevro Corp. 221.82 Million USD -5.642%
Owlet, Inc. 15.21 Million USD -1440.109%
Vicarious Surgical Inc. 14.83 Million USD -1479.982%
Smith & Nephew plc 3.08 Billion USD 92.401%
Sonendo, Inc. 40.35 Million USD -480.761%
STERIS plc 3.38 Billion USD 93.073%
Stryker Corporation 12.99 Billion USD 98.197%
Vapotherm, Inc. 112.39 Million USD -108.505%
Zimmer Biomet Holdings, Inc. 5.99 Billion USD 96.091%